It has been demonstrated that dysregulation of PPARα expression levels and its associated signalling pathways can lead to impaired fatty acid oxidation in the liver and kidney, inducing NAFLD with DKD 42. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.